Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Milestone Pharmaceuticals stock | $7.17

Own Milestone Pharmaceuticals stock in just a few minutes.

Fact checked

Milestone Pharmaceuticals Inc is a biotechnology business based in the US. Milestone Pharmaceuticals shares (MIST) are listed on the NASDAQ and all prices are listed in US Dollars. Milestone Pharmaceuticals employs 28 staff and has a market cap (total outstanding shares value) of USD$220.7 million.

How to buy shares in Milestone Pharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Milestone Pharmaceuticals. Find the stock by name or ticker symbol: MIST. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Milestone Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$7.17, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Milestone Pharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Milestone Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Milestone Pharmaceuticals share price

Use our graph to track the performance of MIST stocks over time.

Milestone Pharmaceuticals shares at a glance

Information last updated 2020-12-09.
Latest market closeUSD$7.17
52-week rangeUSD$1.71 - USD$23.245
50-day moving average USD$6.412
200-day moving average USD$6.3537
Wall St. target priceUSD$13.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-10.837

Buy Milestone Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Milestone Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Milestone Pharmaceuticals price performance over time

Historical closes compared with the close of $7.17 from 2020-12-09

1 week (2021-01-11) 1.70%
1 month (2020-12-18) 4.52%
3 months (2020-10-16) 0.42%
6 months (2020-07-17) 101.97%
1 year (2020-01-17) -61.18%
2 years (2019-01-15) N/A
3 years (2018-01-15) N/A
5 years (2016-01-15) N/A

Milestone Pharmaceuticals financials

Gross profit TTM USD$0
Return on assets TTM -30.34%
Return on equity TTM -50.71%
Profit margin 0%
Book value $4.133
Market capitalisation USD$220.7 million

TTM: trailing 12 months

Shorting Milestone Pharmaceuticals shares

There are currently 348,528 Milestone Pharmaceuticals shares held short by investors – that's known as Milestone Pharmaceuticals's "short interest". This figure is 13.9% down from 404,950 last month.

There are a few different ways that this level of interest in shorting Milestone Pharmaceuticals shares can be evaluated.

Milestone Pharmaceuticals's "short interest ratio" (SIR)

Milestone Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Milestone Pharmaceuticals shares currently shorted divided by the average quantity of Milestone Pharmaceuticals shares traded daily (recently around 195802.24719101). Milestone Pharmaceuticals's SIR currently stands at 1.78. In other words for every 100,000 Milestone Pharmaceuticals shares traded daily on the market, roughly 1780 shares are currently held short.

However Milestone Pharmaceuticals's short interest can also be evaluated against the total number of Milestone Pharmaceuticals shares, or, against the total number of tradable Milestone Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Milestone Pharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Milestone Pharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0168% of the tradable shares (for every 100,000 tradable Milestone Pharmaceuticals shares, roughly 17 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Milestone Pharmaceuticals.

Find out more about how you can short Milestone Pharmaceuticals stock.

Milestone Pharmaceuticals share dividends

We're not expecting Milestone Pharmaceuticals to pay a dividend over the next 12 months.

Milestone Pharmaceuticals overview

Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications. The company was founded in 2003 and is headquartered in Montréal, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site